190 related articles for article (PubMed ID: 38619733)
1. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
[TBL] [Abstract][Full Text] [Related]
2. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
Courtois N; Caspar Y; Maurin M
Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
[TBL] [Abstract][Full Text] [Related]
5. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
6. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
7. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
8. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
[TBL] [Abstract][Full Text] [Related]
9. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
10. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
Abraham N; Kwon DH
FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
[TBL] [Abstract][Full Text] [Related]
12. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
13. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
Singh M; Yau YCW; Wang S; Waters V; Kumar A
Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
[TBL] [Abstract][Full Text] [Related]
14. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
[TBL] [Abstract][Full Text] [Related]
15. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL
J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064
[TBL] [Abstract][Full Text] [Related]
17. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.
Ferreira AG; Leão RS; Carvalho-Assef AP; da Silva ÉA; Firmida Mde C; Folescu TW; Paixão VA; Santana MA; de Abreu e Silva FA; Barth AL; Marques EA
APMIS; 2015 Dec; 123(12):1061-8. PubMed ID: 26522829
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
19. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
20. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
